Form 4 holding
Chief Medical Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Common Stock
- Shares / value
- 43,210
- Estimated value
- $1,626,857
- Report date
- 17 Oct 2023
- Price
- $37.65
- Ownership
- Direct
Alan Seth Krasner
Insider Reports History
- Location
- San Diego, CA
- Owner filing signature
- /s/ Marc Wilson, as attorney-in-fact
- Transaction evidence
- Report rows are grouped by the transaction date disclosed in the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Who this page is about.
1 identity field
SEC source record
Original filing metadata and source links.
1 source field
Source evidence
Original filing metadata and source links.
1 source field
Reported holdings for Alan Seth Krasner
Form 4 holding
Chief Medical Officer
Crinetics Pharmaceuticals, Inc.
- Security class
- Non-qualified stock option (Right to Buy)
- Shares / value
- 153,473
- Estimated value
- Report date
- 17 Oct 2023
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Insider Reports Filed by Alan Seth Krasner
4
CRNX
Crinetics Pharmaceuticals, Inc.
- Report period
- 17 Oct 2023
- Transactions
- 3
- Transaction value
- -$125,930
- Accepted by SEC
- 19 Oct 2023, 17:01
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
CRNX
Crinetics Pharmaceuticals, Inc.
- Report period
- 16 Mar 2023
- Transactions
- 1
- Transaction value
- -$28,881
- Accepted by SEC
- 17 Mar 2023, 17:09
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
CRNX
Crinetics Pharmaceuticals, Inc.
- Report period
- 01 Mar 2023
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 03 Mar 2023, 15:43
- Role
- Chief Medical Officer
- Next action
- Open filing details
5
CRNX
Crinetics Pharmaceuticals, Inc.
- Report period
- 31 Dec 2022
- Transactions
- 2
- Transaction value
- +$21,236
- Accepted by SEC
- 27 Jan 2023, 15:28
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
CRNX
Crinetics Pharmaceuticals, Inc.
- Report period
- 28 Feb 2022
- Transactions
- 2
- Transaction value
- $0
- Accepted by SEC
- 02 Mar 2022, 20:00
- Role
- Chief Medical Officer
- Next action
- Open filing details
4
CRNX
Crinetics Pharmaceuticals, Inc.
- Report period
- 19 Jan 2022
- Transactions
- 3
- Transaction value
- -$61,613
- Accepted by SEC
- 21 Jan 2022, 15:54
- Role
- Chief Medical Officer
- Next action
- Open filing details